Reports for NALOXONE
Ingredient
NALOXONE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-14 | 2017-11-23 | 2352 |
PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Avoided shortage | 2019-03-29 | 2019-05-01 | 79878 |
PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-06-11 | 2019-07-03 | 86234 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-10-03 | 2020-01-24 | 95396 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2021-05-20 | 2021-06-03 | 139725 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140363 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2022-08-18 | 2022-12-02 | 167203 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Actual shortage | 2024-03-07 | 2024-05-09 | 221534 |
MYLAN-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-22 | 2017-04-12 | 3922 |
MYLAN-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-04-20 | 2019-09-18 | 7392 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94048 |
MYLAN-BUPRENORPHINE/NALOXONE | Discontinued | 2019-09-17 | 2019-09-18 | 94044 |
Showing 1 to 2 of 2